CD8A and neoplasm: The potential of DCs to cross-present antigen has initiated many research questions aimed at finding strategies to enhance cross-presentation of DCs in order to improve tumor- and viral-specific CD8+ T cell responses for the treatment of cancer or infectious diseases.